Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Historical Acquisition Tree
Alternative names
epoetin (Epogen) (1 trial)
thalidomide (Thalomid) (1 trial)
Anemia (Phase 2)
Myelodysplastic-Myeloproliferative Diseases (Phase 2)
Myelodysplastic Syndromes (Phase 2)
Myeloproliferative Disorders (Phase 2)
Preleukemia (Phase 2)
Syndrome (Phase 2)
Trials (1 total)
Trial APIs (2 total)